PHARMA NEWS

Clinical research is entering a new era: advances in methodological approaches, the growing integration of real-world evidence, and strengthened patient engagement are reshaping the drug development landscape.1 As the field continues to evolve, an important challenge has emerged: does the evidence we generate truly reflect the populations these medicines are intended to serve? Across industry,

Future-ready pharma teams: building knowledge and capability to navigate a changing NHS

New treatment option expands paediatric HIV care access

Clinical trials are becoming increasingly complex. In a 2023 survey, 70% of investigative site staff said conducting studies had become more difficult over the previous five years. For sponsors, this shows up as delayed decisions, duplicated effort and reduced visibility across their studies. The challenge is rarely a lack of information. More often, it stems

Australian teams advance first‑in‑human multiple myeloma therapy

Designation supports development for post‑hepatectomy liver failure

New treatment reduces pathogenic IgG while preserving B‑cell function

Phase 2 study to assess muscarinic M1 agonist in Alzheimer’s cognition

sBLA covers dMMR/MSI‑H stage II–III rectal cancer

Anthropic, twist and Adaptyv validate 1,320 binders across 15 targets